Abiopharma

NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025

TELA Bio to Announce Third Quarter 2025 Financial Results

CVRx to Present at the Jefferies Global Healthcare Conference in London

Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer

Aligos Therapeutics to Present at Upcoming Investor Conferences

Tandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security Standards

Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer

CORRECTION: Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights

IMUNON Announces Webcast of In-Person R&D Day Highlighting Progress on OVATION 3 Study in Pursuit of First Frontline Immunotherapy for Advanced Ovarian Cancer

SAB BIO to Participate in Upcoming Investor Conferences